New psychoactive substances – mephedrone and violence

Posted · 2 Comments

Writing in Addiction Today, Prof Oscar D’Agnone cautions against buying in too much to how ‘legal highs’ are marketed. Even the more accepted term – new psychoactive substances (NPS) – is not really hitting the nail on the head, since the drugs are not all ‘new’ and many of the ‘new’ ones are very closely […]

Legal highs – not for human consumption

Posted · 6 Comments

Legal highs in Lothian The UK has the largest market for new psychoactive substances (NSP or “legal highs”) in Europe. Scotland is no stranger to them and, as a seminar in Edinburgh heard last week, the Lothian area is seeing a surge in demand, some worrying trends in injecting and significant new presentations due to problems […]

Naloxone is not enough

Posted · 2 Comments

I’m a fan of Take Home Naloxone (THN). I’ve also wondered about how our naloxone programmes might be recovery-focused. Dr Judith Craven wrote a personal piece touching on this a while back. Jason Schwarz picks up on how our expectations might be greater than the impact the drug can actually make. He quotes Andrew Kolodny, from Phoenix […]

Peer-led needle exchange – room for recovery?

Posted · Add Comment

Needle exchange: reducing harm Needle exchanges are recognised within harm reduction services as conferring benefits to injecting drug users. They can help to reduce blood borne virus transmission, but also offer the opportunity to reduce other harms through delivering safer injecting advice, addressing health concerns and trying to engage clients with treatment options. Such services […]